We are live on ! Find out more
NGVT icon

Ingevity

334 hedge funds and large institutions have $3.42B invested in Ingevity in 2019 Q4 according to their latest regulatory filings, with 42 funds opening new positions, 111 increasing their positions, 108 reducing their positions, and 32 closing their positions.

New
Increased
Maintained
Reduced
Closed

31% more first-time investments, than exits

New positions opened: 42 | Existing positions closed: 32

3% more capital invested

Capital invested by funds: $3.31B → $3.42B (+$108M)

3% more repeat investments, than reductions

Existing positions increased: 111 | Existing positions reduced: 108

0.36% more ownership

Funds ownership: 93.31%93.66% (+0.36%)

0% less funds holding

Funds holding: 335334 (-1)

60% less funds holding in top 10

Funds holding in top 10: 52 (-3)

67% less call options, than puts

Call options by funds: $1.01M | Put options by funds: $3.04M

Holders
334
Holders Change
-1
Holders Change %
-0.3%
% of All Funds
6.58%
Holding in Top 10
2
Holding in Top 10 Change
-3
Holding in Top 10 Change %
-60%
% of All Funds
0.04%
New
42
Increased
111
Reduced
108
Closed
32
Calls
$1.01M
Puts
$3.04M
Net Calls
-$2.03M
Net Calls Change
+$20K

NGVT Hedge Fund Activity: Q4 2019 in Review

334 of the 5,075 institutional investors tracked by Wall St. Rank reported a position in Ingevity (NGVT) for Q4 2019, worth a combined $3.42B — up 3.3% from $3.31B a quarter earlier.

Buyers outnumbered sellers: 42 funds opened new NGVT positions and 32 closed out — a net gain of 10 holders — while 111 added to existing stakes and 108 trimmed.

The largest buyer was Goldman Sachs, adding an estimated $24.9M. The largest seller was Capital Research Global Investors, cutting an estimated $29.3M.

  • 334 institutional investors held Ingevity (NGVT) as of Q4 2019, down from 335 in Q3 2019.
  • Funds reported $3.42B of Ingevity stock for Q4 2019, up 3.3% quarter-over-quarter.
  • 42 funds opened new Ingevity positions in Q4 2019 and 32 closed out, a net change of +10 holders.
  • The largest Ingevity buyer in Q4 2019 was Goldman Sachs, an estimated $24.9M added.
  • The largest Ingevity seller in Q4 2019 was Capital Research Global Investors, an estimated $29.3M sold.

Based on aggregated 13F filings for Q4 2019.